Open access · CC-BY
via OpenAlex
Increased Telomere Attrition After Renal Transplantation—Impact of Antimetabolite Therapy
Karin Luttropp, Louise Nordfors, Dagmara McGuinness, Lars M. Wennberg, H. Curley, Tara Quasim, Helena Genberg, John Tyler Sandberg, Isabella Sönnerborg, Martin Schalling, Abdul Rashid Qureshi, Peter F. Barany, Paul G. Shiels, Peter Stenvinkel
Transplantation Direct · 2016 · ▲ 19 citations
Abstract
Background The uremic milieu exposes chronic kidney disease (CKD) patients to premature ageing processes. The impact of renal replacement therapy (dialysis and renal transplantation [RTx]) or immunosuppressive treatment regimens on ageing biomarkers has scarcely been studied. Methods In this study telomere(definition) length in whole blood cells was measured in 49 dialysis patients and 47 RTx patients close to therapy initiation and again after 12 months. Forty-three non-CKD patients were included as controls. Results Non-CKD patients had significantly (P≤ 0.01) longer telomeres than CKD patients. Telomere attrition after 12 months was significantly greater in RTx patients compared to dialysis patients (P= 0.008). RTx patients receiving mycophenolate mofetil (MMF) had a greater (P= 0.007) degree of telomere attrition compared to those treated with azathioprine. After 12 months, folate was significantly higher in RTx patients than in dialysis patients (P< 0.0001), whereas the opposite was true for homocysteine (P< 0.0001). The azathioprine group had lower levels of folate after 12 months than the MMF group (P= 0.003). Conclusions The associations between immunosuppressive therapy, telomere attrition, and changes in folate indicate a link between methyl donor potential, immunosuppressive drugs, and biological ageing. The hypothesis that the increased telomere attrition, observed in the MMF group after RTx, is driven by the immunosuppressive treatment, deserves further attention.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1097/txd.0000000000000629
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Luttropp, K., Nordfors, L., McGuinness, D., Wennberg, L.M., Curley, H., Quasim, T., Genberg, H., Sandberg, J.T., Sönnerborg, I., Schalling, M., Qureshi, A.R., Barany, P.F., Shiels, P.G., & Stenvinkel, P. (2016). Increased Telomere Attrition After Renal Transplantation—Impact of Antimetabolite Therapy. <em>Transplantation Direct</em>. https://doi.org/10.1097/txd.0000000000000629
Vancouver
Luttropp K, Nordfors L, McGuinness D, Wennberg LM, Curley H, Quasim T, et al. Increased Telomere Attrition After Renal Transplantation—Impact of Antimetabolite Therapy. Transplantation Direct. 2016. doi:10.1097/txd.0000000000000629.
BibTeX
@article{karin2016Increa,
title = {Increased Telomere Attrition After Renal Transplantation—Impact of Antimetabolite Therapy},
author = {Karin Luttropp and Louise Nordfors and Dagmara McGuinness and Lars M. Wennberg and H. Curley and Tara Quasim and Helena Genberg and John Tyler Sandberg and Isabella Sönnerborg and Martin Schalling and Abdul Rashid Qureshi and Peter F. Barany and Paul G. Shiels and Peter Stenvinkel},
journal = {Transplantation Direct},
year = {2016},
doi = {10.1097/txd.0000000000000629},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging 2019
Preprint · CC-BY
Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes
Journal of Bone and Mineral Research 2001
Open access · OA
Effects of Daily Treatment with Parathyroid Hormone on Bone Microarchitecture and Turnover in Patients with Osteoporosis: A Paired Biopsy Study
European Respiratory Journal 2016
Open access · OA
Accelerated telomere attrition in children and teenagers with α1-antitrypsin deficiency
Transplantation 2005
Citation only
Nonmyeloablative Conditioning Does Not Prevent Telomere Shortening after Allogeneic Stem Cell Transplantation
ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS 2025
Open access · CC-BY
INTERLEUKIN-6 AND ACUTE PHASE PROTEINS AS BIOMARKERS OF SEPTIC OSTEOARTHRITIS
European Heart Journal 2008
Open access · OA